In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals (original) (raw)
Promising Experimental Anti-SARS-CoV-2 Agent “SLL-0197800”: The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus
Amgad Rabie
2023
View PDFchevron_right
Targeted Drug Repurposing Against the SARS-CoV-2 E channel Identifies Blockers With in vitro Antiviral Activity
Prabhat Tomar
bioRxiv (Cold Spring Harbor Laboratory), 2021
View PDFchevron_right
Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors
Niloofar Mohammadi
Informatics in Medicine Unlocked, 2020
View PDFchevron_right
Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets
ahmed abdullh mohamed
Chemical Papers, 2021
View PDFchevron_right
Computational design for the development of natural molecules as compelling inhibitors against the target SARS-CoV-2: An in-silico attempt
Nagarjuna Palathoti
journal of applied pharmaceutical science, 2022
View PDFchevron_right
Antiviral drug discovery: preparing for the next pandemic
Rosemary Dorrington
Chemical Society Reviews, 2021
View PDFchevron_right
Recent advances in computational drug discovery for therapy against coronavirus SARS-CoV-2
Oleg Kalugin
ScienceRise. Pharmaceutical science, 2023
View PDFchevron_right
Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
Prabhat Tomar
Viruses, 2021
View PDFchevron_right
Computational Determination of Potential Inhibitors of SARS-CoV2 Main Protease
Ly Le
View PDFchevron_right
Potential combination therapy using twenty phytochemicals from twenty plants to prevent SARS- CoV-2 infection: An in silico Approach
Dipjyoti Dey
VirusDisease
View PDFchevron_right
The broad-spectrum antiviral recommendations for drug discovery against COVID-19
Huma Naeem
Drug Metabolism Reviews, 2020
View PDFchevron_right
Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach
Atul Upadhyay
3 Biotech, 2021
View PDFchevron_right
Screening of preferential binding affinity of selected natural compounds to SARS-CoV-2 proteins using in silico methods
Milka Maksimović
Eurasian Journal of Medicine and Oncology, 2020
View PDFchevron_right
Previous and potential mutations of Sars-cov-2 receptors and their interaction with known inhibitors
Ikemefuna Uzochukwu
GSC biological and pharmaceutical sciences, 2023
View PDFchevron_right
Novel SARS-CoV-2 and COVID-2019 Outbreak: Current Perspectives on Plant-Based Antiviral Agents and Complementary Therapy
sevgi gezici
Indian Journal of Pharmaceutical Education and Research, 2020
View PDFchevron_right
SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
Simona Iacob
Frontiers in Pharmacology, 2020
View PDFchevron_right
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Elena Moreno
Nature, 2020
View PDFchevron_right
COVID-19 and SARS-CoV-2: Despite the vaccination, new targets/drugs for treatment and the virus cycle mechanisms still have to be continually investigated
Marcia Rodrigues Amorim
Open Journal of Proteomics and Genomics, 2021
View PDFchevron_right
Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors
Katrina Sleeman
Bioorganic & Medicinal Chemistry Letters, 2008
View PDFchevron_right
In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)
Jahan B. Ghasemi
Informatics in Medicine Unlocked
View PDFchevron_right
Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
Arun B Gurung
Journal of Infection and Public Health, 2021
View PDFchevron_right
SARS-CoV-2 neutralizing antibody development strategies
muge serhatli
TURKISH JOURNAL OF BIOLOGY
View PDFchevron_right
Molecular modelling studies to suggest novel scaffolds against SARS-CoV-2 target enzymes
Ş.Güniz Küçükgüzel
Journal of research in pharmacy, 2021
View PDFchevron_right
Candidate antiviral drugs for COVID-19 and their environmental implications: a comprehensive analysis
Stavros P . Papadakos
Environmental Science and Pollution Research, 2021
View PDFchevron_right
Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms
Mark Harold Paz Mendoza
Journal of Biomolecular Structure and Dynamics, 2020
View PDFchevron_right